The aim is to help them refrain from criminal behavior and develop healthy coping strategies for dealing with their ...

Celcuity Inc. (Nasdaq: CELC) (the 'Company”), a clinical-stage biotechnology company pursuing development of targeted ...

Tecelra will continue to be available to patients without interruption US WorldMeds plans to bring lete-cel to market and will continue dev ...

TD Bank Group has appointed John B. MacIntyre as chair of the board of directors, effective September 1, 2025. MacIntyre has served as an independent director since 2023 and currently chairs the board ...

Universal Health Services, Inc. ( NYSE: UHS) Q2 2025 Earnings Conference Call July 29, 2025 10:00 AM ET Marc D. Miller - CEO, President & Director Steve G. Filton - Executive VP, CFO & Secretary ...

However, many of the dates have either sold out, or are very close to selling out, so one of the best ways to find Paul ...

Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced proposed underwritten public offerings ...

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine ...

Faraday Copper Corp. is pleased to announce that it has completed its previously announced brokered bought deal financing, including the exercise in full of the Underwriters' over-allotment option, ...